An Exploratory Phase 1 Microdose Study of PRX-105

Summary

Exploratory phase 1, first in human, open label, non-randomized, single-dose study of PRX-105, administered intravenously by slow bolus injection to 10 healthy volunteers. The objective is to evaluate the pharmacokinetic profile of PRX-105 without any significant physiological effect in healthy volunteers after a single, intravenous microdose administration.

Timeline

Start

2010-03

Primary completion

2010-05

Completion

2010-08

Drugs

Indications